Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Using Artificial Intelligence to Improve Timeliness of Follow-Up in Breast Cancer Screening.

Journal of the American College of Radiology : JACR·2026
Same author

Trends in Pediatric Imaging From 1997 to 2024 in an Integrated Health Care Setting.

Hospital pediatrics·2026
Same author

In what clinical settings are the MASAI trial results applicable?

Nature reviews. Clinical oncology·2026
Same author

Temporal and geographic analyses of colorectal cancer screening during and after the COVID-19 pandemic in a federally qualified health center.

PloS one·2026
Same author

Outcomes of Density-Targeted Supplemental Breast Magnetic Resonance Imaging Screening by Breast Cancer Risk: Long-Term Health and Economic Considerations.

Annals of internal medicine·2026
Same journal

Established machine learning matches tabular foundation models in clinical predictions.

BMC medical informatics and decision making·2026
Same journal

Explainable AI machine learning framework for chronic kidney disease prediction utilizing electronic health records.

BMC medical informatics and decision making·2026
Same journal

Interpretable SHAP-based machine learning framework for patient satisfaction prediction: a case study in Thammasat University Hospital.

BMC medical informatics and decision making·2026
Same journal

Automated generation of structured breast ultrasound reports using BreastViT and ChatGPT.

BMC medical informatics and decision making·2026
Same journal

Shared decision-making and medication adherence among community adults with chronic diseases: a cross-sectional study in Hubei Province, China.

BMC medical informatics and decision making·2026
Same journal

Classification of periapical radiographic findings for root canal therapy decision support using deep neural networks.

BMC medical informatics and decision making·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Evaluating risk factor assumptions: a simulation-based approach.

Carolyn M Rutter1, Diana L Miglioretti, James E Savarino

  • 1Biostatistics Unit, Group Health Research Institute, Seattle, WA, USA. rutter.c@ghc.org

BMC Medical Informatics and Decision Making
|September 9, 2011
PubMed
Summary
This summary is machine-generated.

Microsimulation models predict disease outcomes. Evaluating risk factor assumptions in these models is crucial for accurately estimating intervention effectiveness in high-risk groups.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Related Experiment Videos

Last Updated: May 29, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

Area of Science:

  • Epidemiology
  • Health Economics
  • Biostatistics

Background:

  • Microsimulation models are key for comparative effectiveness research, predicting individual disease outcomes.
  • Accurate estimation of interventions for high-risk groups requires specifying how risk factors influence disease natural history.
  • A novel method is proposed for evaluating these risk factor assumptions during model development.

Purpose of the Study:

  • To assess the impact of risk factor assumptions on colorectal cancer (CRC) incidence and mortality predictions.
  • To compare the effect of varying screening colonoscopy initiation ages across different risk mechanisms.
  • To understand how non-CRC mortality influences the observed effects of CRC-specific risk factors.

Main Methods:

  • Utilized simulation studies extending the CRC-SPIN model for colorectal cancer.
  • Examined relative rates (RR) of CRC incidence and mortality for cohorts with and without specific risk factors.
  • Compared the impact of different ages for initiating screening colonoscopy under various risk factor scenarios.

Main Results:

  • CRC incidence and mortality RRs decreased with age across all CRC-specific risk factor mechanisms.
  • The rate of change in RRs varied based on the specific risk factor mechanism and its effect strength.
  • Earlier screening initiation consistently increased life years gained, with magnitude varying by risk mechanism.
  • Increased non-CRC mortality attenuated the impact of CRC-specific risk factors on CRC outcomes.

Conclusions:

  • Simulation studies effectively reveal the influence of risk factor assumptions on model predictions.
  • These studies also highlight the data requirements for calibrating risk factor models accurately.
  • The findings underscore the importance of robust risk factor modeling for effective health interventions.